Amphoteric liposomes comprising imino lipids
The invention concerns lipid assemblies, liposomes having an outer surface comprising a mixture of anionic and cationic moieties; wherein at least a portion of the cationic moieties are imino moieties that are essentially charged under physiological conditions, and their use for serum resistant transfection of cells.
1. Lipid assemblies, comprising: anionic and cationic amphiphiles, and a neutral lipid,
wherein the cationic amphiphiles are selected from the group consisting of structures ( 11 ), ( 12 ), and ( 15 ):
wherein:
R 1 and R 2 are each independently alkyl, alkenyl, or alkynyl, wherein the alkyl, alkenyl, or alkynyl has 8 to 24 carbon atoms and 0, 1, or 2 unsaturated bonds;
A and B are each independently absent, —CH 2 —, —CH═, ═CH—, —O—, —NH—, —C(O)—O—, —O—C(O)—, —O—C(O)—NH—, or —NH—C(O)—O—;
D is absent, —CH 2 —, —CH═, ═CH—, —O—, —NH—, —C(O)—O—, —O—C(O)—, —C(O)—NH—, —NH—C(O)—, —O—C(O)—NH—, —NH—C(O)—O—,
m is an integer between 0 and 29;
n is an integer between 0 and 29; and
the imino group comprises a guanido moiety, wherein the imino group is substantially charged under physiological conditions;
wherein the anionic amphiphiles are carboxyl or phosphate lipids, and
wherein the charge ratio between the cationic and anionic amphiphiles is from 0.67 to 1.5.
2. The lipid assemblies of claim 1 , wherein the charge ratio between the cationic and anionic amphiphiles is from 1 to 1.5.
3. The lipid assemblies of claim 1 , wherein the charge ratio between the cationic and anionic amphiphiles is from 1 to 1.22.
4. The lipid assemblies of claim 1 , wherein the lipid assemblies are pH-sensitive, have negative to neutral surface charge under physiological conditions, and mediate cell transfection in the presence of serum.
5. The lipid assemblies of claim 1 , wherein the anionic amphiphiles are carboxyl lipids.
6. The lipid assemblies of claim 1 , wherein the anionic amphiphiles are phosphate lipids.
7. The lipid assemblies of claim 1 , wherein the imino group is:
wherein R 11 and R 12 are, independently of each other, H, —CH 3 or —CH 2 CH 3 , n is 0 or 1, and L is an apolar region of the cationic amphiphile.
8. The lipid assemblies of claim 1 , wherein the cationic amphiphiles are GUADACA.
9. The lipid assemblies of claim 1 , wherein the anionic amphiphiles are selected from the group consisting of CHEMS, DMGS, DOGS, DOPA and POPA.
10. The lipid assemblies of claim 1 , wherein the neutral lipid is selected from the group consisting of cholesterol, phosphatidylcholine, phosphatidylethanolamine, and mixtures thereof.
11. The lipid assemblies of claim 10 , wherein the neutral lipid is cholesterol, and the molar fraction of cholesterol in the lipid assemblies is from 10 to 50 mol %.
12. The lipid assemblies of claim 1 , further comprising PEG lipids.
13. The lipid assemblies of claim 1 , wherein the charge ratio between the cationic and anionic amphiphiles is 1 or less and wherein no PEG lipids are present.
14. The lipid assemblies of claim 1 , further comprising nucleic acid.
15. The lipid assemblies of claim 14 , wherein the nucleic acid is an oligonucleotide.
16. The lipid assemblies of claim 14 , wherein the nucleic acid is polynucleotide, DNA plasmid, linear DNA construct or mRNA.
17. The lipid assemblies of claim 1 , wherein the charge ratio between the cationic and anionic amphiphiles is from 0.67 to 1.25.
18. The lipid assemblies of claim 1 , wherein the guanido moiety is selected from the group consisting of:
wherein L is an apolar region of the cationic amphiphile.
19. A method of transfecting cells, comprising applying the lipid assemblies of claim 1 to the cells in the presence of serum.
20. The method of claim 19 , further comprising applying the lipid assemblies into bloodstream.